Findings come from a year-long study into the perceptions of the pharma sector in the UK
News
Macomics secures £4.24m to accelerate macrophage-based therapeutics portfolio
The company was co-founded in 2019 by Jeffrey Pollard and Luca Cassetta of the University of Edinburgh
AC Immune acquires Parkinson’s disease vaccine candidate
AC Immune is set to acquire Affiris’ entire portfolio of therapeutics targeting alpha-synuclein
Study shows AZ’s COVID-19 jab did not increase the rate of rare blood clots after second dose
Rate of rare blood clots with low platelets after the second dose is comparable to background rates observed in unvaccinated populations
Early data shows CanSinoBIO’s inhaled COVID-19 vaccine triggers immune response
No serious side effects were observed in the Phase I trial
Regeneron, AZ partner on development of novel obesity drugs
Collaboration will focus on developing small molecule medicines targeting GPR75
NICE publishes new draft guideline covering rehabilitation after traumatic injury
A traumatic injury includes any injury that requires admission to hospital at the time of injury, according to NICE
EU backs approval of Moderna’s COVID-19 vaccine in 12-17 year-olds
Study in adolescents met it primary endpoint, successfully bridging immune responses to those observed in an efficacy study in adults
Organon and ObsEva to collaborate on preterm labour treatment
Organon will license the global development, manufacturing and commercial rights to investigational treatment ebopiprant
BioNTech to develop a mRNA-based malaria vaccine
Clinical trial for first vaccine candidate is planned for the end of 2022
Four-drug combo therapy shows benefit for newly-diagnosed myeloma patients
Combo therapy includes carflizomib administered alongside lenalidomide, dexamethasone and cyclophosphamide
Researchers find extending the time between Pfizer doses boosts antibodies
Eight weeks between doses is the ‘sweet spot’ according to researchers
CHMP recommends expanded use for Alexion’s PNH therapy Ultomiris
European drug regulator has recommended Ultomiris for use in children and adolescents with PNH
NICE, PHE publish new antimicrobial prescribing guideline on C. difficile infection
New recommendations outlined include advice for managing C. difficile infection in both community and hospital settings
New plans to improve patient access to mental health services unveiled in England
NHS England has set out new plans to introduce five new waiting time guarantees for mental health services
